FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588565580> ?p ?o ?g. }

• W2588565580 abstract "Abstract Background: Patients with relapsed or refractory Hodgkin (HL) and Non Hodgkin Lymphoma (NHL) have few therapeutic options after salvage therapy and transplant, and new agents are thus needed. MK-0457 is a novel aurora kinase inhibitor (AKI) which leads to polyploidy and G2 arrest by disregulating mitosis. We demonstrate that the addition of vorinostat, a broad spectrum HDACi, leads to the reactivation of proapoptotic and DNA damage response elements leading to enhanced lymphoma cell death. A panel of HL and NHL cell lines was studied with either drug or the combination using MTS, Annexin V, and flow cytometry studies. Results: Vorinostat alone at a dose range of 0.5 – 3 mM reduces cell growth by at least 50% in all lines tested. For example, 1.5 mM vorinostat results in averages of 50% growth reduction and 30% apoptotic cells at 48 hours in the L540 HL cell line. MK-0457 alone at 100 nM – 500 nM results in up to a 50% reduction in cell growth and 20% apoptosis in the tested cell lines. However, the combination of 1.5 mM vorinostat and 100 nM MK-0457 results in 50 – 70% apoptosis of the L540 and KM-H2 Hodgkin cell lines at 48 hours. Cell cycle analyses by FACS show an increased percentage of cells in G2/M with few cells in sub-G1, whereas in combination with vorinostat there is a significant increase in the sub G1 population. Real-time PCR analysis and immunoblotting of L540 cells treated with either single agent or in combination suggest an epigenetic as well as a protein acetylation mechanism for this activity. Prosurvival genes such as bcl-XL and hTERT are downregulated five-fold by combination drug treatment, while the proapoptotic BAK gene is upregulated 1.5 – 2-fold. The p53 tumor suppressor is stabilized both by increased acetylation in response to vorinostat as well as by reduced inhibitory phosphorylation at Ser315 by MK-0457-inhibited aurora kinase, leading to a corresponding increase in the p53 target genes p21 and Noxa. Protein and mRNA levels of c-myc are reduced. Repression of microRNAs (miRNAs) in the myc-regulated polycistronic cluster of miRNAs of chromosome 13, such as miR-17.5p, -17.3p, and 18, is demonstrated with vorinostat and TSA. Conclusions: The HDACi vorinostat leads to both transcriptional and post-transcriptional changes which create a pro-apoptotic milieu, sensitizing the cell to centrosome-acting agents such as the AKI, MK-0457. [We acknowledge Merck Inc for providing Vorinostat, MK-0457, and research support.]<" @default.
• W2588565580 created "2017-02-24" @default.
• W2588565580 creator A5009104622 @default.
• W2588565580 creator A5022795218 @default.
• W2588565580 creator A5039374832 @default.
• W2588565580 creator A5065487922 @default.
• W2588565580 creator A5074672999 @default.
• W2588565580 creator A5091067752 @default.
• W2588565580 date "2008-11-16" @default.
• W2588565580 modified "2023-09-30" @default.
• W2588565580 title "Combination Therapy with Histone Deacetylase Inhibitor Vorinostat Plus Aurora Kinase Inhibitor MK-0457 Leads to Enhanced Lymphoma Cell Killing with Stabilization of p53 and Repression of C-Myc, hTERT, and Myc-Responsive miRNAs" @default.
• W2588565580 doi "https://doi.org/10.1182/blood.v112.11.3628.3628" @default.
• W2588565580 hasPublicationYear "2008" @default.
• W2588565580 type Work @default.
• W2588565580 sameAs 2588565580 @default.
• W2588565580 citedByCount "0" @default.
• W2588565580 crossrefType "journal-article" @default.
• W2588565580 hasAuthorship W2588565580A5009104622 @default.
• W2588565580 hasAuthorship W2588565580A5022795218 @default.
• W2588565580 hasAuthorship W2588565580A5039374832 @default.
• W2588565580 hasAuthorship W2588565580A5065487922 @default.
• W2588565580 hasAuthorship W2588565580A5074672999 @default.
• W2588565580 hasAuthorship W2588565580A5091067752 @default.
• W2588565580 hasConcept C104317684 @default.
• W2588565580 hasConcept C190283241 @default.
• W2588565580 hasConcept C2776202225 @default.
• W2588565580 hasConcept C2776262904 @default.
• W2588565580 hasConcept C2778305200 @default.
• W2588565580 hasConcept C2779707156 @default.
• W2588565580 hasConcept C29537977 @default.
• W2588565580 hasConcept C31573885 @default.
• W2588565580 hasConcept C502942594 @default.
• W2588565580 hasConcept C54355233 @default.
• W2588565580 hasConcept C55493867 @default.
• W2588565580 hasConcept C62112901 @default.
• W2588565580 hasConcept C64927066 @default.
• W2588565580 hasConcept C81885089 @default.
• W2588565580 hasConcept C86803240 @default.
• W2588565580 hasConceptScore W2588565580C104317684 @default.
• W2588565580 hasConceptScore W2588565580C190283241 @default.
• W2588565580 hasConceptScore W2588565580C2776202225 @default.
• W2588565580 hasConceptScore W2588565580C2776262904 @default.
• W2588565580 hasConceptScore W2588565580C2778305200 @default.
• W2588565580 hasConceptScore W2588565580C2779707156 @default.
• W2588565580 hasConceptScore W2588565580C29537977 @default.
• W2588565580 hasConceptScore W2588565580C31573885 @default.
• W2588565580 hasConceptScore W2588565580C502942594 @default.
• W2588565580 hasConceptScore W2588565580C54355233 @default.
• W2588565580 hasConceptScore W2588565580C55493867 @default.
• W2588565580 hasConceptScore W2588565580C62112901 @default.
• W2588565580 hasConceptScore W2588565580C64927066 @default.
• W2588565580 hasConceptScore W2588565580C81885089 @default.
• W2588565580 hasConceptScore W2588565580C86803240 @default.
• W2588565580 hasLocation W25885655801 @default.
• W2588565580 hasOpenAccess W2588565580 @default.
• W2588565580 hasPrimaryLocation W25885655801 @default.
• W2588565580 hasRelatedWork W1980691352 @default.
• W2588565580 hasRelatedWork W2097690191 @default.
• W2588565580 hasRelatedWork W2148396794 @default.
• W2588565580 hasRelatedWork W2270238912 @default.
• W2588565580 hasRelatedWork W2323767515 @default.
• W2588565580 hasRelatedWork W2362853550 @default.
• W2588565580 hasRelatedWork W2486646058 @default.
• W2588565580 hasRelatedWork W2487709308 @default.
• W2588565580 hasRelatedWork W2529740077 @default.
• W2588565580 hasRelatedWork W2563645105 @default.
• W2588565580 hasRelatedWork W2563757607 @default.
• W2588565580 hasRelatedWork W2565756661 @default.
• W2588565580 hasRelatedWork W2568090423 @default.
• W2588565580 hasRelatedWork W2594181272 @default.
• W2588565580 hasRelatedWork W2606328154 @default.
• W2588565580 hasRelatedWork W2618389973 @default.
• W2588565580 hasRelatedWork W2967362211 @default.
• W2588565580 hasRelatedWork W2979566277 @default.
• W2588565580 hasRelatedWork W2979569721 @default.
• W2588565580 hasRelatedWork W2508912318 @default.
• W2588565580 isParatext "false" @default.
• W2588565580 isRetracted "false" @default.
• W2588565580 magId "2588565580" @default.
• W2588565580 workType "article" @default.